5-HT6 receptor (Serbian Wikipedia)
Analysis of information sources in references of the Wikipedia article "5-HT6 receptor" in Serbian language version.
refsWebsite
Global rank
Serbian rank
610th place
653rd place
6th place
5th place
archive.org
- Dawson LA, Nguyen HQ, Li P (2000). „In vivo effects of the 5-HT(6) antagonist SB-271046 on striatal and frontal cortex extracellular concentrations of noradrenaline, dopamine, 5-HT, glutamate and aspartate”. British Journal of Pharmacology. 130 (1): 23—6. PMC 1572041
. PMID 10780993. doi:10.1038/sj.bjp.0703288. - Romero G, Sánchez E, Pujol M, Pérez P, Codony X, Holenz J, Buschmann H, Pauwels PJ (2006). „Efficacy of selective 5-HT6 receptor ligands determined by monitoring 5-HT6 receptor-mediated cAMP signaling pathways”. Br. J. Pharmacol. 148 (8): 1133—43. PMC 1752021 . PMID 16865095. doi:10.1038/sj.bjp.0706827.
- Fisas A, Codony X, Romero G, Dordal A, Giraldo J, Mercé R, Holenz J, Vrang N, Sørensen RV, Heal D, Buschmann H, Pauwels PJ (2006). „Chronic 5-HT6 receptor modulation by E-6837 induces hypophagia and sustained weight loss in diet-induced obese rats”. Br. J. Pharmacol. 148 (7): 973—83. PMC 1751931 . PMID 16783408. doi:10.1038/sj.bjp.0706807.
doi.org
- Kohen R, Metcalf MA, Khan N, Druck T, Huebner K, Lachowicz JE, Meltzer HY, Sibley DR, Roth BL, Hamblin MW (1996). „Cloning, characterization, and chromosomal localization of a human 5-HT6 serotonin receptor”. J. Neurochem. 66 (1): 47—56. PMID 8522988. doi:10.1046/j.1471-4159.1996.66010047.x.
- Woolley ML, Marsden CA, Fone KC (2004). „5-ht6 receptors”. Current Drug Targets. CNS and Neurological Disorders. 3 (1): 59—79. PMID 14965245. doi:10.2174/1568007043482561.
- Kohen, R; Metcalf, MA; Khan, N; et al. (1996). „Cloning, characterization, and chromosomal localization of a human 5-HT6 serotonin receptor”. Journal of Neurochemistry. 66 (1): 47—56. PMID 8522988. doi:10.1046/j.1471-4159.1996.66010047.x.
- Ruat, M; Traiffort, E; Arrang, JM; et al. (1993). „A novel rat serotonin (5-HT6) receptor: molecular cloning, localization and stimulation of cAMP accumulation”. Biochemical and Biophysical Research Communications. 193 (1): 268—76. PMID 8389146. doi:10.1006/bbrc.1993.1619.
- Gérard, C; Martres, MP; Lefèvre, K; et al. (1997). „Immuno-localization of serotonin 5-HT6 receptor-like material in the rat central nervous system”. Brain Research. 746 (1-2): 207—19. PMID 9037500. doi:10.1016/S0006-8993(96)01224-3.
- Hamon, M; Doucet, E; Lefèvre, K; et al. (1999). „Antibodies and antisense oligonucleotide for probing the distribution and putative functions of central 5-HT6 receptors”. Neuropsychopharmacology. 21 (2 Suppl): 68S—76S. PMID 10432491. doi:10.1016/S0893-133X(99)00044-5.
- Dawson LA, Nguyen HQ, Li P (2000). „In vivo effects of the 5-HT(6) antagonist SB-271046 on striatal and frontal cortex extracellular concentrations of noradrenaline, dopamine, 5-HT, glutamate and aspartate”. British Journal of Pharmacology. 130 (1): 23—6. PMC 1572041 . PMID 10780993. doi:10.1038/sj.bjp.0703288.
- Dawson LA, Nguyen HQ, Li P (2001). „The 5-HT(6) receptor antagonist SB-271046 selectively enhances excitatory neurotransmission in the rat frontal cortex and hippocampus”. Neuropsychopharmacology. 25 (5): 662—8. PMID 11682249. doi:10.1016/S0893-133X(01)00265-2.
- King MV, Sleight AJ, Woolley ML, Topham IA, Marsden CA, Fone KC (2004). „5-HT6 receptor antagonists reverse delay-dependent deficits in novel object discrimination by enhancing consolidation--an effect sensitive to NMDA receptor antagonism”. Neuropharmacology. 47 (2): 195—204. PMID 15223298. doi:10.1016/j.neuropharm.2004.03.012.
- Upton N, Chuang TT, Hunter AJ, Virley DJ (2008). „5-HT6 receptor antagonists as novel cognitive enhancing agents for Alzheimer's disease”. Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics. 5 (3): 458—69. PMID 18625457. doi:10.1016/j.nurt.2008.05.008.
- Schechter, LE; Lin, Q; Smith, DL; et al. (2008). „Neuropharmacological profile of novel and selective 5-HT6 receptor agonists: WAY-181187 and WAY-208466”. Neuropsychopharmacology. 33 (6): 1323—35. PMID 17625499. doi:10.1038/sj.npp.1301503.
- Lacroix LP, Dawson LA, Hagan JJ, Heidbreder CA (2004). „5-HT6 receptor antagonist SB-271046 enhances extracellular levels of monoamines in the rat medial prefrontal cortex”. Synapse. 51 (2): 158—64. PMID 14618683. doi:10.1002/syn.10288.
- Trani G, Baddeley SM, Briggs MA, Chuang TT, Deeks NJ, Johnson CN, Khazragi AA, Mead TL, Medhurst AD, Milner PH, Quinn LP, Ray AM, Rivers DA, Stean TO, Stemp G, Trail BK, Witty DR (2008). „Tricyclic azepine derivatives as selective brain penetrant 5-HT6 receptor antagonists”. Bioorg. Med. Chem. Lett. 18 (20): 5698—700. PMID 18793848. doi:10.1016/j.bmcl.2008.08.010.
- Liu KG, Lo JR, Comery TA, Zhang GM, Zhang JY, Kowal DM, Smith DL, Di L, Kerns EH, Schechter LE, Robichaud AJ (2009). „Identification of a series of benzoxazoles as potent 5-HT6 ligands”. Bioorg. Med. Chem. Lett. 19 (4): 1115—7. PMID 19152787. doi:10.1016/j.bmcl.2008.12.107.
- Lee, M; Rangisetty, JB; Pullagurla, MR; et al. (2005). „1-(1-Naphthyl)piperazine as a novel template for 5-HT6 serotonin receptor ligands”. Bioorg. Med. Chem. Lett. 15 (6): 1707—11. PMID 15745826. doi:10.1016/j.bmcl.2005.01.031.
- Sikazwe D, Bondarev ML, Dukat M, Rangisetty JB, Roth BL, Glennon RA (2006). „Binding of sulfonyl-containing arylalkylamines at human 5-HT6 serotonin receptors”. J. Med. Chem. 49 (17): 5217—25. PMID 16913710. doi:10.1021/jm060469q.
- Zhou, P; Yan, Y; Bernotas, R; et al. (2005). „4-(2-Aminoethoxy)-N-(phenylsulfonyl)indoles as novel 5-HT6 receptor ligands”. Bioorg. Med. Chem. Lett. 15 (5): 1393—6. PMID 15713394. doi:10.1016/j.bmcl.2005.01.005.
- Ahmed, M; Briggs, MA; Bromidge, SM; et al. (2005). „Bicyclic heteroarylpiperazines as selective brain penetrant 5-HT6 receptor antagonists”. Bioorg. Med. Chem. Lett. 15 (21): 4867—71. PMID 16143522. doi:10.1016/j.bmcl.2005.06.107.
- Alcalde E, Mesquida N, Frigola J, López-Pérez S, Mercè R (2008). „Indene-based scaffolds. Design and synthesis of novel serotonin 5-HT6 receptor ligands”. Org. Biomol. Chem. 6 (20): 3795—810. PMID 18843410. doi:10.1039/b808641a.
- Mattsson C, Sonesson C, Sandahl A, Greiner HE, Gassen M, Plaschke J, Leibrock J, Böttcher H (2005). „2-Alkyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indoles as novel 5-HT6 receptor agonists”. Bioorg. Med. Chem. Lett. 15 (19): 4230—4. PMID 16055331. doi:10.1016/j.bmcl.2005.06.067.
- Glennon RA, Lee M, Rangisetty JB, Dukat M, Roth BL, Savage JE, McBride A, Rauser L, Hufeisen S, Lee DK (2000). „2-Substituted tryptamines: agents with selectivity for 5-HT6 serotonin receptors”. J. Med. Chem. 43 (5): 1011—8. PMID 10715164. doi:10.1021/jm990550b.
- Cole DC, Stock JR, Lennox WJ, Bernotas RC, Ellingboe JW, Boikess S, Coupet J, Smith DL, Leung L, Zhang GM, Feng X, Kelly MF, Galante R, Huang P, Dawson LA, Marquis K, Rosenzweig-Lipson S, Beyer CE, Schechter LE (2007). „Discovery of N1-(6-chloroimidazo[2,1-b][1,3]thiazole-5-sulfonyl)tryptamine as a potent, selective, and orally active 5-HT(6) receptor agonist”. Journal of Medicinal Chemistry. 50 (23): 5535—8. PMID 17948978. doi:10.1021/jm070521y.
- Alcalde E, Mesquida N, López-Pérez S, Frigola J, Mercè R (2009). „Indene-based scaffolds. 2. An indole-indene switch: discovery of novel indenylsulfonamides as 5-HT6 serotonin receptor agonists”. J. Med. Chem. 52 (3): 675—87. PMID 19159187. doi:10.1021/jm8009469.
- Romero G, Sánchez E, Pujol M, Pérez P, Codony X, Holenz J, Buschmann H, Pauwels PJ (2006). „Efficacy of selective 5-HT6 receptor ligands determined by monitoring 5-HT6 receptor-mediated cAMP signaling pathways”. Br. J. Pharmacol. 148 (8): 1133—43. PMC 1752021 . PMID 16865095. doi:10.1038/sj.bjp.0706827.
- Fisas A, Codony X, Romero G, Dordal A, Giraldo J, Mercé R, Holenz J, Vrang N, Sørensen RV, Heal D, Buschmann H, Pauwels PJ (2006). „Chronic 5-HT6 receptor modulation by E-6837 induces hypophagia and sustained weight loss in diet-induced obese rats”. Br. J. Pharmacol. 148 (7): 973—83. PMC 1751931 . PMID 16783408. doi:10.1038/sj.bjp.0706807.
- Hugerth A, Brisander M, Wrange U, Kritikos M, Norrlind B, Svensson M, Bisrat M, Ostelius J (2006). „Physical characterization of anhydrous and hydrous forms of the hydrochloride salt of BVT.5182 a novel 5-HT6 receptor antagonist”. Drug Dev Ind Pharm. 32 (2): 185—96. PMID 16537199. doi:10.1080/03639040500466122.
- Heal DJ, Smith SL, Fisas A, Codony X, Buschmann H (2008). „Selective 5-HT6 receptor ligands: progress in the development of a novel pharmacological approach to the treatment of obesity and related metabolic disorders”. Pharmacol. Ther. 117 (2): 207—31. PMID 18068807. doi:10.1016/j.pharmthera.2007.08.006.
- Wu, J; Li, Q; Bezprozvanny, I (2008). „Evaluation of Dimebon in cellular model of Huntington's disease.”. Molecular neurodegeneration. 3: 15. PMC 2577671 . PMID 18939977. doi:10.1186/1750-1326-3-15.
- Ivachtchenko AV, Frolov EB, Mitkin OD, Kysil VM, Khvat AV, Okun IM, Tkachenko SE (2009). „Synthesis and biological evaluation of novel gamma-carboline analogues of Dimebon as potent 5-HT6 receptor antagonists”. Bioorganic & Medicinal Chemistry Letters. 19 (12): 3183—7. PMID 19443217. doi:10.1016/j.bmcl.2009.04.128.
elsevier.com
linkinghub.elsevier.com
- Ruat, M; Traiffort, E; Arrang, JM; et al. (1993). „A novel rat serotonin (5-HT6) receptor: molecular cloning, localization and stimulation of cAMP accumulation”. Biochemical and Biophysical Research Communications. 193 (1): 268—76. PMID 8389146. doi:10.1006/bbrc.1993.1619.
- Gérard, C; Martres, MP; Lefèvre, K; et al. (1997). „Immuno-localization of serotonin 5-HT6 receptor-like material in the rat central nervous system”. Brain Research. 746 (1-2): 207—19. PMID 9037500. doi:10.1016/S0006-8993(96)01224-3.
- King MV, Sleight AJ, Woolley ML, Topham IA, Marsden CA, Fone KC (2004). „5-HT6 receptor antagonists reverse delay-dependent deficits in novel object discrimination by enhancing consolidation--an effect sensitive to NMDA receptor antagonism”. Neuropharmacology. 47 (2): 195—204. PMID 15223298. doi:10.1016/j.neuropharm.2004.03.012.
- Upton N, Chuang TT, Hunter AJ, Virley DJ (2008). „5-HT6 receptor antagonists as novel cognitive enhancing agents for Alzheimer's disease”. Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics. 5 (3): 458—69. PMID 18625457. doi:10.1016/j.nurt.2008.05.008.
nih.gov
ncbi.nlm.nih.gov
- Kohen R, Metcalf MA, Khan N, Druck T, Huebner K, Lachowicz JE, Meltzer HY, Sibley DR, Roth BL, Hamblin MW (1996). „Cloning, characterization, and chromosomal localization of a human 5-HT6 serotonin receptor”. J. Neurochem. 66 (1): 47—56. PMID 8522988. doi:10.1046/j.1471-4159.1996.66010047.x.
- „Entrez Gene: HTR6 5-hydroxytryptamine (serotonin) receptor 6”.
- Woolley ML, Marsden CA, Fone KC (2004). „5-ht6 receptors”. Current Drug Targets. CNS and Neurological Disorders. 3 (1): 59—79. PMID 14965245. doi:10.2174/1568007043482561.
- Kohen, R; Metcalf, MA; Khan, N; et al. (1996). „Cloning, characterization, and chromosomal localization of a human 5-HT6 serotonin receptor”. Journal of Neurochemistry. 66 (1): 47—56. PMID 8522988. doi:10.1046/j.1471-4159.1996.66010047.x.
- Ruat, M; Traiffort, E; Arrang, JM; et al. (1993). „A novel rat serotonin (5-HT6) receptor: molecular cloning, localization and stimulation of cAMP accumulation”. Biochemical and Biophysical Research Communications. 193 (1): 268—76. PMID 8389146. doi:10.1006/bbrc.1993.1619.
- Gérard, C; Martres, MP; Lefèvre, K; et al. (1997). „Immuno-localization of serotonin 5-HT6 receptor-like material in the rat central nervous system”. Brain Research. 746 (1-2): 207—19. PMID 9037500. doi:10.1016/S0006-8993(96)01224-3.
- Hamon, M; Doucet, E; Lefèvre, K; et al. (1999). „Antibodies and antisense oligonucleotide for probing the distribution and putative functions of central 5-HT6 receptors”. Neuropsychopharmacology. 21 (2 Suppl): 68S—76S. PMID 10432491. doi:10.1016/S0893-133X(99)00044-5.
- Dawson LA, Nguyen HQ, Li P (2000). „In vivo effects of the 5-HT(6) antagonist SB-271046 on striatal and frontal cortex extracellular concentrations of noradrenaline, dopamine, 5-HT, glutamate and aspartate”. British Journal of Pharmacology. 130 (1): 23—6. PMC 1572041 . PMID 10780993. doi:10.1038/sj.bjp.0703288.
- Dawson LA, Nguyen HQ, Li P (2001). „The 5-HT(6) receptor antagonist SB-271046 selectively enhances excitatory neurotransmission in the rat frontal cortex and hippocampus”. Neuropsychopharmacology. 25 (5): 662—8. PMID 11682249. doi:10.1016/S0893-133X(01)00265-2.
- King MV, Sleight AJ, Woolley ML, Topham IA, Marsden CA, Fone KC (2004). „5-HT6 receptor antagonists reverse delay-dependent deficits in novel object discrimination by enhancing consolidation--an effect sensitive to NMDA receptor antagonism”. Neuropharmacology. 47 (2): 195—204. PMID 15223298. doi:10.1016/j.neuropharm.2004.03.012.
- Upton N, Chuang TT, Hunter AJ, Virley DJ (2008). „5-HT6 receptor antagonists as novel cognitive enhancing agents for Alzheimer's disease”. Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics. 5 (3): 458—69. PMID 18625457. doi:10.1016/j.nurt.2008.05.008.
- Schechter, LE; Lin, Q; Smith, DL; et al. (2008). „Neuropharmacological profile of novel and selective 5-HT6 receptor agonists: WAY-181187 and WAY-208466”. Neuropsychopharmacology. 33 (6): 1323—35. PMID 17625499. doi:10.1038/sj.npp.1301503.
- Lacroix LP, Dawson LA, Hagan JJ, Heidbreder CA (2004). „5-HT6 receptor antagonist SB-271046 enhances extracellular levels of monoamines in the rat medial prefrontal cortex”. Synapse. 51 (2): 158—64. PMID 14618683. doi:10.1002/syn.10288.
- Trani G, Baddeley SM, Briggs MA, Chuang TT, Deeks NJ, Johnson CN, Khazragi AA, Mead TL, Medhurst AD, Milner PH, Quinn LP, Ray AM, Rivers DA, Stean TO, Stemp G, Trail BK, Witty DR (2008). „Tricyclic azepine derivatives as selective brain penetrant 5-HT6 receptor antagonists”. Bioorg. Med. Chem. Lett. 18 (20): 5698—700. PMID 18793848. doi:10.1016/j.bmcl.2008.08.010.
- Liu KG, Lo JR, Comery TA, Zhang GM, Zhang JY, Kowal DM, Smith DL, Di L, Kerns EH, Schechter LE, Robichaud AJ (2009). „Identification of a series of benzoxazoles as potent 5-HT6 ligands”. Bioorg. Med. Chem. Lett. 19 (4): 1115—7. PMID 19152787. doi:10.1016/j.bmcl.2008.12.107.
- Lee, M; Rangisetty, JB; Pullagurla, MR; et al. (2005). „1-(1-Naphthyl)piperazine as a novel template for 5-HT6 serotonin receptor ligands”. Bioorg. Med. Chem. Lett. 15 (6): 1707—11. PMID 15745826. doi:10.1016/j.bmcl.2005.01.031.
- Sikazwe D, Bondarev ML, Dukat M, Rangisetty JB, Roth BL, Glennon RA (2006). „Binding of sulfonyl-containing arylalkylamines at human 5-HT6 serotonin receptors”. J. Med. Chem. 49 (17): 5217—25. PMID 16913710. doi:10.1021/jm060469q.
- Zhou, P; Yan, Y; Bernotas, R; et al. (2005). „4-(2-Aminoethoxy)-N-(phenylsulfonyl)indoles as novel 5-HT6 receptor ligands”. Bioorg. Med. Chem. Lett. 15 (5): 1393—6. PMID 15713394. doi:10.1016/j.bmcl.2005.01.005.
- Ahmed, M; Briggs, MA; Bromidge, SM; et al. (2005). „Bicyclic heteroarylpiperazines as selective brain penetrant 5-HT6 receptor antagonists”. Bioorg. Med. Chem. Lett. 15 (21): 4867—71. PMID 16143522. doi:10.1016/j.bmcl.2005.06.107.
- Alcalde E, Mesquida N, Frigola J, López-Pérez S, Mercè R (2008). „Indene-based scaffolds. Design and synthesis of novel serotonin 5-HT6 receptor ligands”. Org. Biomol. Chem. 6 (20): 3795—810. PMID 18843410. doi:10.1039/b808641a.
- Mattsson C, Sonesson C, Sandahl A, Greiner HE, Gassen M, Plaschke J, Leibrock J, Böttcher H (2005). „2-Alkyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indoles as novel 5-HT6 receptor agonists”. Bioorg. Med. Chem. Lett. 15 (19): 4230—4. PMID 16055331. doi:10.1016/j.bmcl.2005.06.067.
- Glennon RA, Lee M, Rangisetty JB, Dukat M, Roth BL, Savage JE, McBride A, Rauser L, Hufeisen S, Lee DK (2000). „2-Substituted tryptamines: agents with selectivity for 5-HT6 serotonin receptors”. J. Med. Chem. 43 (5): 1011—8. PMID 10715164. doi:10.1021/jm990550b.
- Cole DC, Stock JR, Lennox WJ, Bernotas RC, Ellingboe JW, Boikess S, Coupet J, Smith DL, Leung L, Zhang GM, Feng X, Kelly MF, Galante R, Huang P, Dawson LA, Marquis K, Rosenzweig-Lipson S, Beyer CE, Schechter LE (2007). „Discovery of N1-(6-chloroimidazo[2,1-b][1,3]thiazole-5-sulfonyl)tryptamine as a potent, selective, and orally active 5-HT(6) receptor agonist”. Journal of Medicinal Chemistry. 50 (23): 5535—8. PMID 17948978. doi:10.1021/jm070521y.
- Alcalde E, Mesquida N, López-Pérez S, Frigola J, Mercè R (2009). „Indene-based scaffolds. 2. An indole-indene switch: discovery of novel indenylsulfonamides as 5-HT6 serotonin receptor agonists”. J. Med. Chem. 52 (3): 675—87. PMID 19159187. doi:10.1021/jm8009469.
- Romero G, Sánchez E, Pujol M, Pérez P, Codony X, Holenz J, Buschmann H, Pauwels PJ (2006). „Efficacy of selective 5-HT6 receptor ligands determined by monitoring 5-HT6 receptor-mediated cAMP signaling pathways”. Br. J. Pharmacol. 148 (8): 1133—43. PMC 1752021 . PMID 16865095. doi:10.1038/sj.bjp.0706827.
- Fisas A, Codony X, Romero G, Dordal A, Giraldo J, Mercé R, Holenz J, Vrang N, Sørensen RV, Heal D, Buschmann H, Pauwels PJ (2006). „Chronic 5-HT6 receptor modulation by E-6837 induces hypophagia and sustained weight loss in diet-induced obese rats”. Br. J. Pharmacol. 148 (7): 973—83. PMC 1751931 . PMID 16783408. doi:10.1038/sj.bjp.0706807.
- Hugerth A, Brisander M, Wrange U, Kritikos M, Norrlind B, Svensson M, Bisrat M, Ostelius J (2006). „Physical characterization of anhydrous and hydrous forms of the hydrochloride salt of BVT.5182 a novel 5-HT6 receptor antagonist”. Drug Dev Ind Pharm. 32 (2): 185—96. PMID 16537199. doi:10.1080/03639040500466122.
- Heal DJ, Smith SL, Fisas A, Codony X, Buschmann H (2008). „Selective 5-HT6 receptor ligands: progress in the development of a novel pharmacological approach to the treatment of obesity and related metabolic disorders”. Pharmacol. Ther. 117 (2): 207—31. PMID 18068807. doi:10.1016/j.pharmthera.2007.08.006.
- Wu, J; Li, Q; Bezprozvanny, I (2008). „Evaluation of Dimebon in cellular model of Huntington's disease.”. Molecular neurodegeneration. 3: 15. PMC 2577671 . PMID 18939977. doi:10.1186/1750-1326-3-15.
- Ivachtchenko AV, Frolov EB, Mitkin OD, Kysil VM, Khvat AV, Okun IM, Tkachenko SE (2009). „Synthesis and biological evaluation of novel gamma-carboline analogues of Dimebon as potent 5-HT6 receptor antagonists”. Bioorganic & Medicinal Chemistry Letters. 19 (12): 3183—7. PMID 19443217. doi:10.1016/j.bmcl.2009.04.128.
- Liu KG, Robichaud AJ, Bernotas RC, Yan Y, Lo JR, Zhang MY, Hughes ZA, Huselton C, Zhang GM, Zhang JY, Kowal DM, Smith DL, Schechter LE, Comery TA (2010). „5-Piperazinyl-3-sulfonylindazoles as potent and selective 5-hydroxytryptamine-6 antagonists”. J Med Chem. 53 (21): 7639—46. PMID 20932009.
pubmed.ncbi.nlm.nih.gov
- Kohen, R; Metcalf, MA; Khan, N; et al. (1996). „Cloning, characterization, and chromosomal localization of a human 5-HT6 serotonin receptor”. Journal of Neurochemistry. 66 (1): 47—56. PMID 8522988. doi:10.1046/j.1471-4159.1996.66010047.x.